M&A Critique

Eris Lifesciences on Acquisition Spree to expand its branded formulations portfolio

Recently, Eris Lifesciences Limited announced the acquisition of the ‘branded Formulation Business’ of Biocon Biologics Limited pertaining to the Indian territory through slump sale. In addition, ELL also announced a foreign acquisition.

Eris Lifesciences Limited (“ELL” or “Eris”) is a publicly listed Indian pharma company and is a leading player in the domestic branded formulations market. Establis...

Already a user? Sign in

Aniruddha Jain